TY - JOUR
T1 - Asymmetric Silica Nanoparticles with Tunable Head-Tail Structures Enhance Hemocompatibility and Maturation of Immune Cells
AU - Abbaraju, Prasanna Lakshmi
AU - Meka, Anand Kumar
AU - Song, Hao
AU - Yang, Yannan
AU - Jambhrunkar, Manasi
AU - Zhang, Jun
AU - Xu, Chun
AU - Yu, Meihua
AU - Yu, Chengzhong
N1 - Publisher Copyright:
© 2017 American Chemical Society.
PY - 2017/5/10
Y1 - 2017/5/10
N2 - Asymmetric mesoporous silica nanoparticles (MSNs) with controllable head-tail structures have been successfully synthesized. The head particle type is tunable (solid or porous), and the tail has dendritic large pores. The tail length and tail coverage on head particles are adjustable. Compared to spherical silica nanoparticles with a solid structure (Stöber spheres) or large-pore symmetrical MSNs with fully covered tails, asymmetrical head-tail MSNs (HTMSNs) show superior hemocompatibility due to reduced membrane deformation of red blood cells and decreased level of reactive oxygen species. Moreover, compared to Stöber spheres, asymmetrical HTMSNs exhibit a higher level of uptake and in vitro maturation of immune cells including dendritic cells and macrophage. This study has provided a new family of nanocarriers with potential applications in vaccine development and immunotherapy.
AB - Asymmetric mesoporous silica nanoparticles (MSNs) with controllable head-tail structures have been successfully synthesized. The head particle type is tunable (solid or porous), and the tail has dendritic large pores. The tail length and tail coverage on head particles are adjustable. Compared to spherical silica nanoparticles with a solid structure (Stöber spheres) or large-pore symmetrical MSNs with fully covered tails, asymmetrical head-tail MSNs (HTMSNs) show superior hemocompatibility due to reduced membrane deformation of red blood cells and decreased level of reactive oxygen species. Moreover, compared to Stöber spheres, asymmetrical HTMSNs exhibit a higher level of uptake and in vitro maturation of immune cells including dendritic cells and macrophage. This study has provided a new family of nanocarriers with potential applications in vaccine development and immunotherapy.
UR - https://www.scopus.com/pages/publications/85019172791
U2 - 10.1021/jacs.6b12622
DO - 10.1021/jacs.6b12622
M3 - 文章
C2 - 28440642
AN - SCOPUS:85019172791
SN - 0002-7863
VL - 139
SP - 6321
EP - 6328
JO - Journal of the American Chemical Society
JF - Journal of the American Chemical Society
IS - 18
ER -